相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anisomycin treatment enhances TRAIL-mediated apoptosis in renal carcinoma cells through the down-regulation of Bcl-2, c-FLIP(L) and Mcl-1
Bo Ram Seo et al.
BIOCHIMIE (2013)
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
L. Y. Dimberg et al.
ONCOGENE (2013)
Hyperthermia enhances mapatumumab-induced apoptotic death through ubiquitin-mediated degradation of cellular FLIP(long) in human colon cancer cells
X. Song et al.
CELL DEATH & DISEASE (2013)
Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
Michael J. Lee et al.
CELL (2012)
Regulation of CD95/Fas signaling at the DISC
I. N. Lavrik et al.
CELL DEATH AND DIFFERENTIATION (2012)
Stem cell gene Girdin: a potential early liver metastasis predictor of colorectal cancer
Chen Liu et al.
MOLECULAR BIOLOGY REPORTS (2012)
The Role of Bcl-xL in Synergistic Induction of Apoptosis by Mapatumumab and Oxaliplatin in Combination with Hyperthermia on Human Colon Cancer
Xinxin Song et al.
MOLECULAR CANCER RESEARCH (2012)
Prognostic significance of Bcl-xL gene expression in human colorectal cancer
Jin-Song Yang et al.
ACTA HISTOCHEMICA (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Targeting Trail Towards the Clinic
Devalingam Mahalingam et al.
CURRENT DRUG TARGETS (2011)
Oxaliplatin Sensitizes Human Colon Cancer Cells to TRAIL Through JNK-Dependent Phosphorylation of Bcl-xL
Zineb El Fajoui et al.
GASTROENTEROLOGY (2011)
The NEDD8-Activating Enzyme Inhibitor, MLN4924, Cooperates with TRAIL to Augment Apoptosis through Facilitating c-FLIP Degradation in Head and Neck Cancer Cells
Liqun Zhao et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Isolated Hepatic Perfusion with High-Dose Melphalan Results in Immediate Alterations in Tumor Gene Expression in Patients with Metastatic Ocular Melanoma
Sheelu Varghese et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma
A. Younes et al.
BRITISH JOURNAL OF CANCER (2010)
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
T. Trarbach et al.
BRITISH JOURNAL OF CANCER (2010)
Effect of Hyperthermia in Combination With TRAIL on the JNK-Bim Signal Transduction Pathway and Growth of Xenograft Tumors
Marco A. Alcala et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
A Phase I Study of Hyperthermic Isolated Hepatic Perfusion with Oxaliplatin in the Treatment of Unresectable Liver Metastases from Colorectal Cancer
Herbert J. Zeh et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
Constantijne H. Mom et al.
CLINICAL CANCER RESEARCH (2009)
A stochastic model for cancer stem cell origin in metastatic colon cancer
Christine Odoux et al.
CANCER RESEARCH (2008)
Cellular FLICE-like inhibitory protein (c-FLIP): A novel target for cancer therapy
Ahmad R. Safa et al.
CURRENT CANCER DRUG TARGETS (2008)
Identification of the Major Phosphorylation Site in Bcl-xL Induced by Microtubule Inhibitors and Analysis of Its Functional Significance
Meenakshi Upreti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Involvement of c-FLIP and survivin down-regulation in flexible heteroarotinoid-induced apoptosis and enhancement of TRAIL-initiated apoptosis in lung cancer cells
Yidan Lin et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer
F. Anthony Greco et al.
LUNG CANCER (2008)
FLIP and the death effector domain family
J. W. Yu et al.
ONCOGENE (2008)
Significance of Bcl-xL in human colon carcinoma
You-Li Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Effect of hyperthermia and chemotherapeutic agents on TRAIL-induced cell death in human colon cancer cells
Jinsang Yoo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis
Imtiaz A. Mawji et al.
CANCER RESEARCH (2007)
Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients
Gustave J. Ullenhag et al.
CLINICAL CANCER RESEARCH (2007)
Mechanisms of specificity in protein phosphorylation (vol 8, pg 530, 2007)
Jeffrey A. Ubersax et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications
P. Korkolopoulou et al.
HISTOPATHOLOGY (2007)
Mechanisms of specificity in protein phosphorylation
Jeffrey A. Ubersax et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
c-FLIP: A key regulator of colorectal cancer cell death
Timothy R. Wilson et al.
CANCER RESEARCH (2007)
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death
DB Longley et al.
ONCOGENE (2006)
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
LD Zhang et al.
CANCER GENE THERAPY (2005)
Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy
HR Alexander et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells
JM Cummins et al.
CANCER RESEARCH (2004)
Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines
D Atallah et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2004)
Whole-body hyperthermia (41.8°C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer:: a phase II study
S Hegewisch-Becker et al.
ANNALS OF ONCOLOGY (2002)
Treatment of liver metastases, an update on the possibilities and results
T Ruers et al.
EUROPEAN JOURNAL OF CANCER (2002)
FLICE-inhibitory proteins: Regulators of death receptor-mediated apoptosis
A Krueger et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex
A Krueger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy
YJ Lee et al.
CANCER GENE THERAPY (2001)
p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells
T Bartke et al.
ONCOGENE (2001)
Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies
SK Libutti et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2000)